Patent · US Active

Recombinant rhabdovirus encoding for a CD80 extracellular domain Fc-fusion protein

US12171795B2 · kind B2 · utility

0Cited by

0References

15Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Philipp Mueller · Waldshut-Tiengen, DE
Klaus Erb · Mittelbiberach, DE
Patrik ERLMANN · Neu Götzens, AT
Guido Wollmann · Innsbruck, AT

Key dates

Filing date	Jun 2, 2021
Grant date	Dec 24, 2024
Priority date	—
Expiry date	Dec 30, 2042

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the field of oncolytic viruses and in particular to a recombinant rhabdovirus, such as vesicular stomatitis virus encoding in its genome for a CD80 extracellular domain Fc-fusion protein. The invention is further directed to the use of the recombinant virus in the treatment of cancer, and also to methods for producing such viruses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.